Neonatal morbidity occurs despite pulmonary maturity prior to 39 weeks gestation.

OBJECTIVE: To compare outcomes among late-preterm or early-term neonates according to fetal lung maturity (FLM) status. STUDY DESIGN: We conducted a retrospective cohort study of 234 eligible singletons delivered after FLM testing before 39 weeks gestation at our center over a 2-year time period. A primary composite neonatal outcome included death and major morbidities. RESULT: The overall rate of primary composite morbidity was 25/46 (52.2%) and 61/188 (32.4%) in the immature/transitional and mature groups, respectively. After adjustment for confounders including gestational age, the composite outcome was not significantly different; adjusted odds ratio (aOR)=1.4 (confidence interval (CI)=0.7-3.0). The rate of respiratory distress syndrome was significantly higher in the immature/transitional group; odds ratio=3.4 (CI=1.1-10.3) as expected. CONCLUSION: FLM status did not correlate with the spectrum of neonatal morbidities in late-preterm and early-term births. Neonatal complications remained common in both groups.

Enhancement of DNA micro-array analysis using a shear-driven micro-channel flow system.

A very simple micro-channel flow system is used to investigate the potential gain in hybridization rate stemming from the induction of a convective flow past the surface of a DNA micro-array. Reporting on a series of preliminary experiments wherein a two-dimensional convective flow is created past the surface of a conventional micro-array slide, the analysis time could be brought down from overnight waiting (16 h) to some 10 to 30 min. The experiments open the road towards the development of novel, convection-driven hybridization systems yielding shorter analysis times, and/or lower detection limits.

Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species.

A canarypox-based (ALVAC) recombinant expressing the rabies G glycoprotein has been utilized to assess in vitro and in vivo biological properties of the canarypox virus vector system. In vitro studies have shown that no replication of the virus can be detected on six human-derived cell lines, nor can the virus be readily adapted to replicate on non-avian cells. Expression of the rabies G can be detected on all cell lines analyzed in the absence of productive viral replication. Analysis of viral-specific DNA accumulation indicated that the block in the replication cycle in the human cell lines analyzed occurred prior to DNA replication. The exact nature of the block, however, remains unknown. The concept of using a non-replicating immunization vehicle has been demonstrated through extensive in vivo studies in a range of species including non-human primates and humans. The results of such in vivo studies have exemplified the safety and immunogenicity of the ALVAC vaccine vector.